InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,307.01
(
-0.27%
)
US TECH 100
18,388.00
(
0.88%
)
Dow Jones
39,671.04
(
-0.51%
)
Brent Oil
82.31
(
0.96%
)
Bitcoin
69,750.24
(
0.94%
)
Post# of 801
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

PETERDENIEL2003

Send PM Follow Ignore
Followers 4
Posts 324
Boards Moderated 0
Alias Born 08/20/2010

PETERDENIEL2003

Re: None

Monday, 08/01/2011 3:21:26 PM

Monday, August 01, 2011 3:21:26 PM

Post# of 801
Altrazeal..USFDA approval/Amelexanox for CANCER SORE..

http://www.uluruinc.com/press_releases/ULURU_Inc_Announces_Filing_of_a_510_k_%20for_Altrazeal_Collagen.pdf

Amlexanox 5% paste is used for the treatment of cancer sores. A Phase IV clinical study conducted in Northern Ireland and results confirmed that amlexanox 5% paste was effective in preventing the formation of an ulcer when used at the first sign or symptom of the disease. As of December 31, 2010, Contract Pharmaceuticals Ltd. Canada is the Company’s contract manufacturer for all markets, including the United States.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up